#USA #Boston #Data Intelligence #ArisGlobal #XDI

ArisGlobal Launches XDI: Transforming Life Sciences with AI

In February 2026, ArisGlobal, a pioneering technology company specializing in artificial intelligence for the life sciences sector, unveiled its groundbreaking product, XDI—its Data Intelligence Cortex. This launch took place at the Breakthrough 2026 event, marking a significant step in the synthesis of complex data sets into actionable intelligence for life sciences organizations.

Addressing Data Overload

As the life sciences industry grapples with increasing volumes of fragmented data emerging from various systems, it faces the challenge of transforming this potential information overload into a strategic advantage. The crux for companies lies not merely in accessing diverse datasets but in making consistent, explainable decisions based on them. XDI provides a transformative solution by linking insights across domains and integrating contextual learning. This enables organizations to shift from a reactive stance towards anticipating risks and seizing opportunities effectively.

How XDI Works

Unlike traditional platforms that require data consolidation in a single location, XDI intelligently engages with data wherever it resides. By federating meaning across different systems, it allows for comprehensive reasoning that is both auditable and scalable across clinical, regulatory, quality assurance, medical affairs, and risk-benefit assessment functions.

Aman Wasan, CEO of ArisGlobal, remarked, “XDI represents a major leap forward in our vision of evolving from an AI-centric organization to a data intelligence titan in the life sciences field. Today’s challenge for life sciences companies is no longer about whether to adopt AI but how to implement it at scale while deriving multi-domain data intelligence.” As a result, XDI promises to deliver high-level intelligence for decision-making, recommending actions backed by solid reasoning, thus enabling swift, risk-free regulatory compliance.

Key Features of XDI

XDI's initial offerings encompass a unified intelligence layer that is tailored to three operational domains:

• - Pharmacovigilance Operational Intelligence: This feature revolutionizes pharmacovigilance processes, transforming them from reactive to proactive systems. It claims to reduce compliance effort by 70-80% and significantly minimizes quality control burdens by 75% through continuous quality checks and intelligent risk recommendations.
• - Risk-Benefit Intelligence: This intelligence layer enables predictive signal management based on robust evidence, with signal detection speeding up by over 30%. Additionally, it decreases operational noise in signal workflows by approximating 40%, reducing cycle times from weeks down to mere days.
• - Regulatory Operational Intelligence: By providing insights derived from real-time multi-domain data, this feature streamlines regulatory compliance efforts, promising reductions similar to those found in pharmacovigilance, with compliance efforts also decreasing by 70-80% and quality controls by 75%.

A Trust-Based Design Approach

XDI is built upon ArisGlobal’s “Trust by Design” framework, which ensures robust AI governance and integrated auditability through its NavaX AI governance model. This strategic positioning guarantees regulatory defenses throughout the entire AI lifecycle, mitigating risks associated with non-compliance.

Looking Ahead

With over 300 clients globally, including leading pharmaceutical, biotechnology, and medical device firms, ArisGlobal continues to leverage advanced technology and sector expertise to not only meet compliance mandates but to turn them into strategic assets. For further information, potential customers can visit www.arisglobal.com/xdi-data-intelligence-cortex or follow ArisGlobal on LinkedIn for the latest updates and innovations in life sciences technology.

In summary, ArisGlobal's XDI embodies a significant innovation aimed at addressing the evolving challenges of data in life sciences, paving the way for smarter, more efficient decision-making processes that prioritize regulatory integrity and operational excellence.